Effect of Dietary Composite Probiotic Supplementation on the Microbiota of Different Oral Sites in Cats.
Mingrui ZhangYingyue CuiXiaoying MeiLongxian LiHaotian WangYingying LiYi WuPublished in: Veterinary sciences (2024)
Probiotics demonstrated effectiveness in modulating oral microbiota and improving oral health in humans and rodents. However, its effects and applications on the oral microbiota of cats remain underexplored. Twelve healthy cats were randomly assigned to a control group (CON) and a composite probiotic group (CPG) for a 42-day trial. The CPG diet included additional supplementation of Bifidobacterium animalis subsp. lactis HN019, Lactobacillus acidophilus NCFM, and Lactobacillus casei LC-11, each at approximately 1 × 10 10 CFU/kg. On days 0 and 42, microbial samples were collected from the gingiva, tooth surfaces, and tongue of all cats for 16S rRNA gene sequencing. Bacteroidetes, Firmicutes, and Proteobacteria were the dominant phyla across all oral sites. The CPG treatment enriched seven genera, such as Moraxella , Actinomyces , and Frederiksenia in the gingiva. Meanwhile, Bergeyella and Streptococcus were enriched on the tooth surfaces, while Bergeyella , Flavobacterium , and Luteimonas were enriched on the tongue. Furthermore, the composite probiotic effectively suppressed eight genera, such as Bacteroides , Desulfovibrio , and Filifactor in the gingiva of CPG cats, as well as Helcococcus, Lentimicrobium, and Campylobacter on tooth surfaces, and Porphyromonas, Treponema, and Fusibacter on the tongue. These findings suggest that the composite probiotic used in this study modulates the feline oral microbiota by supporting beneficial or commensal bacteria and inhibiting oral pathogens, demonstrating potential to improve oral health in cats.
Keyphrases
- oral health
- dna methylation
- biofilm formation
- randomized controlled trial
- systematic review
- lactic acid
- signaling pathway
- mass spectrometry
- study protocol
- genome wide
- risk assessment
- candida albicans
- copy number
- pseudomonas aeruginosa
- high resolution
- antimicrobial resistance
- cystic fibrosis
- transcription factor
- phase iii
- tandem mass spectrometry